Lexaria Bioscience Corp. (LEXX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Lexaria Bioscience Corp.

NASDAQ: LEXX · Real-Time Price · USD
0.88
-0.01 (-1.07%)
At close: Oct 03, 2025, 3:59 PM
0.87
-0.77%
After-hours: Oct 03, 2025, 07:54 PM EDT

Lexaria Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is September - August.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Aug 31, 2024 Aug 31, 2023 Aug 31, 2022 Aug 31, 2021
Cash & Equivalents
6.5M 1.35M 5.81M 10.92M
Short-Term Investments
55.81K 125.64K 347.33K 833.84K
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
63.58K n/a n/a n/a
Receivables
154.48K 175.25K 201.78K 342.4K
Inventory
n/a n/a 38.42K 29.65K
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
7.9M 2.2M 6.98M 12.44M
Property-Plant & Equipment
389.55K 421.59K 367.95K 459.25K
Goodwill & Intangibles
516.68K 462.63K 488.46K 364.62K
Total Long-Term Assets
969.8K 884.21K 856.41K 823.88K
Total Assets
8.87M 3.08M 7.83M 13.27M
Account Payables
371.35K 225.04K 25.85K 59.89K
Deferred Revenue
4.96K n/a n/a n/a
Short-Term Debt
n/a n/a 42.59K 7.93K
Other Current Liabilities
n/a n/a 51.71K 1.05K
Total Current Liabilities
1.1M 267.74K 194.04K 153.28K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
109.32K 136.17K 7.4K 49.99K
Total Liabilities
1.21M 403.91K 201.44K 203.26K
Total Debt
137.37K 163.97K 49.99K 97.32K
Book Value
7.66M 2.68M 7.63M 13.06M
Book Value Per Share
0.62 0.41 1.30 2.97
Common Stock
15.81K 8.09K 5.95K 5.73K
Retained Earnings
-51.56M -45.76M -39.1M -31.83M
Comprehensive Income
-19.82K n/a n/a n/a
Shareholders Equity
8.04M 3.04M 7.95M 13.27M
Total Investments
55.81K 125.64K 347.33K 833.84K